619 related articles for article (PubMed ID: 28300575)
21. Clinical outcome of dedifferentiated liposarcoma in the extremities: A retrospective case series of 7 patients.
Kito M; Yoshimura Y; Isobe K; Aoki K; Suzuki S; Tanaka A; Okamoto M; Sano K; Kato H
J Orthop Sci; 2016 Sep; 21(5):673-7. PubMed ID: 27317086
[TBL] [Abstract][Full Text] [Related]
22. HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon.
Italiano A; Bianchini L; Keslair F; Bonnafous S; Cardot-Leccia N; Coindre JM; Dumollard JM; Hofman P; Leroux A; Mainguené C; Peyrottes I; Ranchere-Vince D; Terrier P; Tran A; Gual P; Pedeutour F
Int J Cancer; 2008 May; 122(10):2233-41. PubMed ID: 18214854
[TBL] [Abstract][Full Text] [Related]
23. What Are the Results of Resection of Localized Dedifferentiated Liposarcomas in the Extremities?
Nakata E; Kunisada T; Hasei J; Nakahara R; Yanai H; Toji T; Inoue Ct H; Ozaki T
Clin Orthop Relat Res; 2020 Nov; 478(11):2550-2561. PubMed ID: 33112583
[TBL] [Abstract][Full Text] [Related]
24. Detection of MDM2 amplification by shallow whole genome sequencing of cell-free DNA of patients with dedifferentiated liposarcoma.
Przybyl J; Spans L; Ganjoo K; Bui N; Mohler D; Norton J; Poultsides G; Debiec-Rychter M; van de Rijn M
PLoS One; 2022; 17(1):e0262272. PubMed ID: 34986184
[TBL] [Abstract][Full Text] [Related]
25. Degree of
Bill KLJ; Seligson ND; Hays JL; Awasthi A; Demoret B; Stets CW; Duggan MC; Bupathi M; Brock GN; Millis SZ; Shakya R; Timmers CD; Wakely PE; Pollock RE; Chen JL
Oncologist; 2019 Jul; 24(7):989-996. PubMed ID: 31019022
[TBL] [Abstract][Full Text] [Related]
26. Liposarcomas of the mediastinum and thorax: a clinicopathologic and molecular cytogenetic study of 24 cases, emphasizing unusual and diverse histologic features.
Boland JM; Colby TV; Folpe AL
Am J Surg Pathol; 2012 Sep; 36(9):1395-403. PubMed ID: 22895273
[TBL] [Abstract][Full Text] [Related]
27. Molecular Characterization of a Rare Dedifferentiated Liposarcoma With Rhabdomyosarcomatous Differentiation in a 24 Year Old.
Olson N; Gularte-Mérida R; Selenica P; Da Cruz Paula A; Alemar B; Weigelt B; Lefferts J; Linos K
Int J Surg Pathol; 2020 Jun; 28(4):454-463. PubMed ID: 31801397
[No Abstract] [Full Text] [Related]
28. High level of CDK4 amplification is a poor prognostic factor in well-differentiated and dedifferentiated liposarcoma.
Lee SE; Kim YJ; Kwon MJ; Choi DI; Lee J; Cho J; Seo SW; Kim SJ; Shin YK; Choi YL
Histol Histopathol; 2014 Jan; 29(1):127-38. PubMed ID: 23852861
[TBL] [Abstract][Full Text] [Related]
29. High amplification levels of MDM2 and CDK4 correlate with poor outcome in patients with dedifferentiated liposarcoma: A cytogenomic microarray analysis of 47 cases.
Ricciotti RW; Baraff AJ; Jour G; Kyriss M; Wu Y; Liu Y; Li SC; Hoch B; Liu YJ
Cancer Genet; 2017 Dec; 218-219():69-80. PubMed ID: 29153098
[TBL] [Abstract][Full Text] [Related]
30. Dedifferentiated liposarcoma: a clinicopathological analysis of 155 cases with a proposal for an expanded definition of dedifferentiation.
Henricks WH; Chu YC; Goldblum JR; Weiss SW
Am J Surg Pathol; 1997 Mar; 21(3):271-81. PubMed ID: 9060596
[TBL] [Abstract][Full Text] [Related]
31. Fibrosarcoma-like lipomatous neoplasm: a reappraisal of so-called spindle cell liposarcoma defining a unique lipomatous tumor unrelated to other liposarcomas.
Deyrup AT; Chibon F; Guillou L; Lagarde P; Coindre JM; Weiss SW
Am J Surg Pathol; 2013 Sep; 37(9):1373-8. PubMed ID: 23887155
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of HMGA2, CDK4, and JUN amplification in well-differentiated and dedifferentiated liposarcomas.
Saâda-Bouzid E; Burel-Vandenbos F; Ranchère-Vince D; Birtwisle-Peyrottes I; Chetaille B; Bouvier C; Château MC; Peoc'h M; Battistella M; Bazin A; Gal J; Michiels JF; Coindre JM; Pedeutour F; Bianchini L
Mod Pathol; 2015 Nov; 28(11):1404-14. PubMed ID: 26336885
[TBL] [Abstract][Full Text] [Related]
33. An experimental model for the study of well-differentiated and dedifferentiated liposarcoma; deregulation of targetable tyrosine kinase receptors.
Peng T; Zhang P; Liu J; Nguyen T; Bolshakov S; Belousov R; Young ED; Wang X; Brewer K; López-Terrada DH; Oliveira AM; Lazar AJ; Lev D
Lab Invest; 2011 Mar; 91(3):392-403. PubMed ID: 21060307
[TBL] [Abstract][Full Text] [Related]
34. Chromosome-12 copy number alterations and MDM2, CDK4 and TP53 expression in soft tissue liposarcoma.
Segura-Sánchez J; González-Cámpora R; Pareja-Megia MJ; García-Escudero A; Galera-Ruiz H; López-Beltrán A
Anticancer Res; 2006; 26(6C):4937-42. PubMed ID: 17214366
[TBL] [Abstract][Full Text] [Related]
35. Intraperitoneal dedifferentiated liposarcoma showing MDM2 amplification: case report.
Grifasi C; Calogero A; Carlomagno N; Campione S; D'Armiento FP; Renda A
World J Surg Oncol; 2013 Nov; 11():305. PubMed ID: 24279301
[TBL] [Abstract][Full Text] [Related]
36. MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data.
Binh MB; Sastre-Garau X; Guillou L; de Pinieux G; Terrier P; Lagacé R; Aurias A; Hostein I; Coindre JM
Am J Surg Pathol; 2005 Oct; 29(10):1340-7. PubMed ID: 16160477
[TBL] [Abstract][Full Text] [Related]
37. Liposarcoma of the pleural cavity.
Kawai T; Nakashima H; Washimi K; Yokose T; Matsuo T; Nakayama M; Shinohara N; Kuroda H; Ishida K; Akiba J; Ishikawa M; Urabe S; Shiraishi J; Shiraishi T; Sakamoto A; Matsukuma S
Hum Pathol; 2023 Jun; 136():105-113. PubMed ID: 37023867
[TBL] [Abstract][Full Text] [Related]
38. Epigenetic alteration of p16INK4a gene in dedifferentiation of liposarcoma.
He M; Aisner S; Benevenia J; Patterson F; Harrison LE; Hameed M
Pathol Res Pract; 2009; 205(6):386-94. PubMed ID: 19186005
[TBL] [Abstract][Full Text] [Related]
39. Osteogenic differentiation in dedifferentiated liposarcoma: a study of 36 cases in comparison to the cases without ossification.
Yamashita K; Kohashi K; Yamada Y; Ishii T; Nishida Y; Urakawa H; Ito I; Takahashi M; Inoue T; Ito M; Ohara Y; Oda Y; Toyokuni S
Histopathology; 2018 Apr; 72(5):729-738. PubMed ID: 29076540
[TBL] [Abstract][Full Text] [Related]
40. Alternative lengthening of telomeres and loss of ATRX are frequent events in pleomorphic and dedifferentiated liposarcomas.
Lee JC; Jeng YM; Liau JY; Tsai JH; Hsu HH; Yang CY
Mod Pathol; 2015 Aug; 28(8):1064-73. PubMed ID: 26022452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]